Morgan Stanley Kiora Pharmaceuticals Inc Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	SELL	$0.36 - $0.68 $5 - $10	-16 Reduced 4.58%	333 $0
Q2 2022 Aug 15, 2022	SELL	$0.36 - $0.68 $5 - $10	-16 Reduced 4.58%	333 $0
Q1 2022 Oct 27, 2022	BUY	$0.54 - $1.27 $8 - $20	16 Added 4.8%	349 $0
Q1 2022 May 13, 2022	BUY	$0.54 - $1.27 $8 - $19	15 Added 4.49%	349 $0
Q4 2021 Feb 14, 2022	BUY	$0.86 - $2.11 $287 - $704	334 New	334 $1,000

Ticker KPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 919,078
Market Cap $3.43M
Description
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.